|

From Benadryl to Real Progress: Why the FDA’s New Decision on Hormone Therapy Matters

Finally, good news for midlife women — the FDA just removed its warning on hormone therapy. Here’s what it means for you.

This past summer, I shared a story about my “appointment from hell.”

You remember — the one where a doctor told me to try Benadryl for chronic vaginal burning.

That post hit a nerve. So many women wrote to say “oh my god, me too.” Different doctors, same dismissal. Different symptoms, same silence.

And honestly, it’s no wonder we’re all exhausted, pissed off, and ready to fight back after being wronged by the U.S. healthcare system — over and over again.

But today, for the first time in a long time, I actually have good news.

Something is shifting.

The FDA — yes, the same organization that stamped a giant “DANGER” label on hormone therapy more than two decades ago — just announced it’s removing the black box warning about breast cancer from menopause hormone therapy.

And you know what? It’s about damn time.


A Little History (and a Lot of Damage)

Let’s rewind to 2002.

That year, a massive study called the Women’s Health Initiative linked hormone therapy to increased risks of breast cancer, heart disease, and stroke. The media went wild. The message to women was loud and clear: “Hormones will kill you.”

Doctors panicked. Prescriptions plummeted. The FDA slapped a black box warning — its most serious kind — on nearly every hormone therapy product.

And just like that, millions of women stopped their treatments overnight.

Hot flashes returned with a vengeance. Sleep disappeared. Vaginal tissues thinned and tore. Moods tanked. Libido vanished. And an entire generation of women learned that their suffering was safer than seeking help.

That fear has lasted twenty years.

Even today, in 2025, I sat across from my gynecologist who shrugged when I asked if my symptoms might be hormone-related. Who told me I wasn’t “in menopause” because I still had a period. Who handed me Benadryl instead of real answers.

That’s what the black box warning did. It didn’t just scare patients — it scared doctors, too.


What’s Changing — and Why

Fast forward to now.

After decades of new research, data re-analysis, and expert consensus, the FDA has finally acknowledged what menopause specialists have been saying for years: the original warning overstated the risks and understated the benefits.

Here’s the truth:

  • The increased risk of breast cancer found in early studies was small — and largely seen in older women who started hormone therapy many years after menopause.
  • For women in their 40s and 50s who start hormones around the time of menopause, the benefits often outweigh the risks.
  • The type of hormone and how it’s delivered (pill, patch, gel, cream) matter — a lot.
  • Newer formulations and lower doses are safer, more personalized, and far more effective.

So, the FDA’s decision to remove the black box warning doesn’t mean “hormones are risk-free.” It means the conversation just got a lot more honest.


Why This Feels Personal

When I read the announcement, I felt… relief. And rage.

Relief that science is finally catching up to what many of us have lived and known: that hormone therapy, when used thoughtfully, can be life-changing — even life-saving.

And rage because of how many women have suffered unnecessarily while waiting for this.

Think about it. How many women were told to “just deal with it”, cried in their cars after being dismissed by their doctors? How many marriages, jobs, and sense of self were quietly eroded by symptoms that could have been treated — but weren’t, because of fear?

It makes my blood boil.

But it also gives me hope, because maybe now, when a woman walks into her doctor’s office asking for help, she won’t be told to take Benadryl. She’ll be told, “Let’s talk about your options.”

Maybe now, she’ll be met with care, not condescension.


What This Means for You (and for All of Us)

If you’re a woman in midlife, here’s what this FDA update means:

  • You have options. Hormone therapy is no longer the medical boogeyman it’s been made out to be.
  • You can ask questions. If your doctor shuts you down, find a new one. You deserve someone who keeps up with current science.
  • You’re allowed to advocate for yourself. You don’t need to prove you’re suffering “enough” to deserve treatment.
  • You can individualize your care. There are many forms of hormone therapy — systemic (patch, pill, gel) and local (vaginal creams, tablets, rings). Your needs are unique.
  • You can combine therapies. Hormones can be part of a bigger wellness strategy — along with nutrition, strength training, sleep, and stress support.

This decision doesn’t mean every woman should take hormones. It means every woman should have accurate information and real choice.


The Bigger Picture: A Cultural Shift

This isn’t just about estrogen and progesterone.

It’s about a system finally being forced to listen.

Women have been dismissed, misdiagnosed, and ignored for generations — told to “tough it out” or that their pain was “just aging.”

Now, science and advocacy are colliding in a powerful way. The FDA’s move is a recognition — however overdue — that women’s health deserves nuance, respect, and honesty.

But it didn’t happen in a vacuum. It happened because women started speaking up.
Because we’re sharing our stories, demanding better care, and refusing to be silenced.

Change happens when we make noise. When we stop apologizing for taking up space. When we roar.


Moving Forward

The black box warning may be gone, but the culture of dismissal isn’t — not yet.

Doctors still need education. Medical schools still need better menopause training. Women still need affordable access to the treatments that can change their lives.

But this moment? It’s progress.

It’s proof that when women unite, advocate, and demand better, things do change.

So if you’ve been hesitant to talk to your doctor about hormones, consider this your sign to revisit the conversation. Ask questions. Bring research. Bring your fire.

Because we’re not crazy.
We’re not hysterical.
We’re informed, powerful, midlife women — and we’re done suffering in silence.


We deserve care, not dismissal.
And the FDA’s decision is one more step toward finally getting it.


Ready to Keep the Conversation Going?

If this resonates with you — if you’re ready to learn, connect, and feel supported through your own midlife transition — join us for one of our upcoming Empowered Through Menopause workshops or subscribe to the newsletter for wellness insights, hormone education, and real talk about this stage of life.

Because knowledge is power. And we’re just getting started.

One Comment

  1. The interpretation of the huge government supported study (Women’s Health Initiative) of hrt released 20 years ago was flawed in so many more ways than implicating hrt in breast cancer risk. Ignoring those interpretations and relying on a smaller subset of that study that targeted women actually in menopause and not post, I took hrt for 10 years. In an attempt to REDUCE my risk of heart disease, osteoporosis, and Alzheimer’s. So far so good, and no breast cancer either!
    It also delayed the onset of menopause. Hot flashes and night sweats well into my 70s.

Comments are closed.